BiotechTube
Home/Syntax Bio/John Craighead, PhD
JC

John Craighead, PhD

CEO

Syntax Bio

Therapeutic Areas

Type 1 Diabetes

Syntax Bio Pipeline

DrugIndicationPhase
Pancreatic Beta Cell TherapyType 1 DiabetesPreclinical

Leadership Team at Syntax Bio

RC
Ryan Clarke, PhD
Cofounder, CTO
BM
Brad Merrill, PhD
Cofounder, Head of Innovation
NB
Niko Balanis, PhD
Cofounder, VP Data Sci & Molecular Bio
NT
Nick Timmins, PhD
CSO
AM
Andy May, DPhil
Executive Chairman
View full Syntax Bio profile